HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Guillermo
Izquierdo Ayuso
Publicaciones en las que colabora con Guillermo Izquierdo Ayuso (61)
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2020
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
-
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
Scientific Reports, Vol. 10, Núm. 1
-
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
Neurology and Therapy, Vol. 9, Núm. 2, pp. 443-457
-
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (I)
Revista de neurologia, Vol. 70, Núm. 10, pp. 379-390
-
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (II)
Revista de neurologia, Vol. 70, Núm. 11, pp. 417-429
2019
-
Review of the novelties presented at the 2018 ECTRIMS congress: 11th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 68, Núm. 11, pp. 468-479
-
Review of the novelties presented at the 2018 ectrims congress: 11th post-ectrims meeting (I)
Revista de Neurologia, Vol. 68, Núm. 10, pp. 431-441
-
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856
2018
-
A guide to treating gait impairment with prolonged-release fampridine (Fampyra ® ) in patients with multiple sclerosis
Neurologia
-
Review of the novelties from the 2017 ECTRIMS congress, presented at the 10th post-ectrims meeting (I)
Revista de Neurologia, Vol. 67, Núm. 1, pp. 15-27
-
Review of the novelties from the 2017 ectrims congress, presented at the 10th post-ectrims meeting (II)
Revista de Neurologia, Vol. 67, Núm. 2, pp. 50-62
2017
-
Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)
Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84
-
Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)
Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40
-
Sodium intake and multiple sclerosis activity and progression in BENEFIT
Annals of Neurology, Vol. 82, Núm. 1, pp. 20-29
-
Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort
European Journal of Clinical Investigation, Vol. 47, Núm. 2, pp. 158-166
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
-
Respuesta al tratamiento con interferón beta en pacientes con esclerosis múltiple. Validación del Rio Score
Revista de Neurologia, Vol. 63, Núm. 4, pp. 145-150
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627